A Randomized Placebo-Controlled Study of the Efficacy and Safety of Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever
Phase of Trial: Phase III
Latest Information Update: 25 Jul 2017
At a glance
- Drugs Anakinra (Primary)
- Indications Familial Mediterranean fever
- Focus Therapeutic Use
- 26 Nov 2016 New trial record
- 11 Nov 2016 Primary endpoint (Number of patients with less than a mean of one FMF attack per month) has been met according to the results published in the Arthritis and Rheumatology.
- 11 Nov 2016 Results published in the Arthritis and Rheumatology.